Skip to main content

Food Hypersensitivity

4
Pipeline Programs
3
Companies
6
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Monoclonal Antibody
1100%
+ 5 programs with unclassified modality

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
5 programs
2
2
Baked MilkPhase 21 trial
Open label peanut OITPhase 21 trial
Baked MilkPhase 11 trial
E. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3Phase 11 trial
A Registry for the Food Allergy CommunityN/A1 trial
Active Trials
NCT04653324Recruiting23,000Est. Aug 2027
NCT00578656Completed220Est. Feb 2011
NCT00850668Completed15Est. Oct 2010
+2 more trials
Genentech
GenentechCA - Oceanside
1 program
OmalizumabPHASE_2Monoclonal Antibody1 trial
Active Trials
NCT06934200Recruiting32Est. Oct 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
GenentechOmalizumab
Allergy TherapeuticsOpen label peanut OIT
Allergy TherapeuticsBaked Milk
Allergy TherapeuticsE. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3
Allergy TherapeuticsBaked Milk
Allergy TherapeuticsA Registry for the Food Allergy Community

Clinical Trials (6)

Total enrollment: 23,457 patients across 6 trials

NCT06934200GenentechOmalizumab

Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels

Start: May 2025Est. completion: Oct 202732 patients
Phase 2Recruiting
NCT01814241Allergy TherapeuticsOpen label peanut OIT

Mechanisms of Desensitization During Peanut Oral Immunotherapy

Start: Apr 2013Est. completion: Dec 201520 patients
Phase 2Completed
NCT00778258Allergy TherapeuticsBaked Milk

Study of Milk Allergy and Tolerance in Children

Start: Aug 2008Est. completion: Nov 2014170 patients
Phase 2Completed
NCT00850668Allergy TherapeuticsE. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3

Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults

Start: Oct 2009Est. completion: Oct 201015 patients
Phase 1Completed
NCT00578656Allergy TherapeuticsBaked Milk

An Interventional Study of Milk Allergy

Start: Jun 2004Est. completion: Feb 2011220 patients
Phase 1Completed
NCT04653324Allergy TherapeuticsA Registry for the Food Allergy Community

A Registry for the Food Allergy Community

Start: Aug 2017Est. completion: Aug 202723,000 patients
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 23,457 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.